Product image of Lenalidomide Amarox (Lenalidomide) supplied by GNH India

Lenalidomide Amarox

Active Ingredient:
Lenalidomide
Origin:
EU

Lenalidomide Amarox (Lenalidomide)

Lenalidomide, the active ingredient in Lenalidomide Amarox, is an immunomodulatory agent (IMiD) presented as an oral formulation for oral use. It is employed in the treatment of certain blood cancers, specifically multiple myeloma and myelodysplastic syndromes, in adult patients.

GNH India supplies Lenalidomide Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and clinical use. Customers benefit from reliable logistics and responsive technical support throughout the supply chain.

Manufacturer / TM Owner

Amarox Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lenalidomide is an immunomodulatory agent used in hematologic malignancies and related bone‑marrow disorders.

  • Multiple Myeloma: reduces disease progression and improves survival when combined with standard therapies.
  • Myelodysplastic Syndromes with del(5q): induces transfusion independence and cytogenetic remission.
  • Myelodysplastic Syndromes (non‑del(5q)): investigated in clinical studies for potential hematologic benefit.

How It Works

  • Lenalidomide binds to the cereblon component of the CRL4CRBN E3 ubiquitin ligase complex, altering its substrate specificity. This leads to ubiquitination and proteasomal degradation of transcription factors Ikaros and Aiolos, resulting in anti‑angiogenic, immunomodulatory, and anti‑proliferative effects that inhibit malignant plasma cell growth.

Side Effects

Lenalidomide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Fatigue: persistent tiredness reported by many patients.
  • Neutropenia: reduced neutrophil count increasing infection risk.
  • Thrombocytopenia: lowered platelet levels leading to bleeding tendency.
  • Diarrhea: loose stools that may affect hydration.
  • Constipation: difficulty passing stools.
  • Rash: mild skin eruptions.

Serious or Rare Side Effects

  • Venous thromboembolism: formation of blood clots in veins.
  • Severe neutropenia: profound drop in neutrophils requiring medical intervention.
  • Severe thrombocytopenia: significant platelet depletion causing hemorrhage.
  • Allergic reactions: anaphylaxis or severe skin reactions.
  • Tumor lysis syndrome: rapid tumor cell breakdown with metabolic disturbances.
  • Second primary malignancies: emergence of new cancers during therapy.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor safety parameters.

  • Pregnancy: safety not established; avoid use in pregnant women.
  • Renal impairment: dose adjustment may be required based on renal function.
  • Hematologic monitoring: perform regular complete blood counts to detect cytopenias.
  • Thromboembolic risk: assess risk and consider prophylactic anticoagulation.
  • Drug interactions: review concomitant medications for potential interactions.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Avoid Interactions

Lenalidomide can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: may increase lenalidomide exposure.
  • Anticoagulants: heightened risk of bleeding.
  • Live vaccines: potential for uncontrolled infection.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may exacerbate renal toxicity.
  • Diuretics: can affect electrolyte balance.
  • Certain antibiotics (e.g., fluoroquinolones): monitor blood counts for additive myelosuppression.

Frequently Asked Questions

Lenalidomide Amarox is used primarily for the treatment of multiple myeloma and myelodysplastic syndromes, especially those with a del(5q) chromosomal abnormality. It may also be considered in clinical studies for other hematologic disorders under specialist supervision.

Lenalidomide binds to cereblon, a component of the CRL4CRBN E3 ubiquitin ligase complex, altering its activity. This triggers the degradation of transcription factors Ikaros and Aiolos, which leads to anti‑angiogenic, immunomodulatory, and anti‑proliferative effects that suppress malignant plasma cells.

The specific dose and schedule of Lenalidomide Amarox are determined by the prescribing clinician based on the patient’s diagnosis, disease stage, renal function, and other individual factors. Healthcare professionals should follow the latest clinical guidelines and product labeling.

Safety data for Lenalidomide in pregnancy and lactation are limited. The drug is generally contraindicated in pregnant women because of potential fetal harm, and breastfeeding is not recommended while receiving therapy. Women of child‑bearing potential should use effective contraception.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lenalidomide belongs to the immunomodulatory drug class and is often used in combination with proteasome inhibitors or dexamethasone. Compared with traditional chemotherapy, it offers a targeted mechanism, oral administration, and a distinct side‑effect profile, but selection depends on disease characteristics and prior therapies.

Lenalidomide Amarox should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Lenalidomide Amarox is taken orally, usually with or without food, as directed by the prescribing physician. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include severe neutropenia, thrombocytopenia, venous thromboembolism, and rare occurrences of second primary malignancies. Patients should be monitored regularly for blood count changes and signs of clot formation, and any concerning symptoms should be reported promptly.

Lenalidomide is contraindicated in patients with known hypersensitivity to the drug or its excipients, in pregnant women, and in individuals with uncontrolled severe infections. Caution is also advised for patients with significant renal impairment or a history of thromboembolic events.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lenalidomide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT